Prof. Dr. Miroslaw Markiewicz | Cancer Cell Biology | Best Researcher Award
Prof. Dr. Miroslaw Markiewicz , Faculty of Medicine, Collegium Medicum, University of Rzeszow , Poland
Mirosลaw Markiewicz is a distinguished medical professional specializing in hematology, internal medicine, and bone marrow transplantation. With over three decades of experience in the medical field, he holds the title of Professor and has made significant contributions to the advancement of hematopoietic stem cell transplantation (HSCT) and hematological research. He earned his MD from the Medical University of Silesia in 1989, followed by a fellowship in 1990. Throughout his career, he has worked in prestigious institutions such as the Medical University of Silesia, Katowice, Poland, and the Albany Medical College in New York. Professor Markiewicz’s research has led to numerous high-impact publications, and he is known for his expertise in myelodysplastic syndrome (MDS), graft-versus-host disease (GVHD), and treatment outcomes in bone marrow transplantation. His commitment to research and clinical excellence has earned him recognition as a leader in his field.
Publication Profile:ย
Strengths for the Award:
Prof. Mirosลaw Markiewicz is a leading expert in the field of hematology, particularly in hematopoietic stem cell transplantation (HSCT), graft-versus-host disease (GVHD), and myelodysplastic syndrome (MDS). His vast clinical experience and academic achievements, including over 114 publications with an impressive impact factor (IF 217.467) and a Hirsch Index of 12, demonstrate his dedication to advancing medical science. Prof. Markiewiczโs research contributions have been instrumental in improving patient outcomes in hematology, particularly in understanding conditioning regimens for HSCT, and exploring genetic and environmental factors in diseases like multiple myeloma. His leadership roles in various institutions and collaborative work with other prominent scientists further underscore his position as a top researcher in his field.
Areas for Improvements:
While Prof. Markiewicz has an extensive publication record, further engagement in multi-disciplinary research approaches could strengthen his contributions to immunotherapy and the intersection of hematology and precision medicine. Additionally, more involvement in international collaborative research projects could expand the global impact of his findings.
Education:
Mirosลaw Markiewicz completed his academic journey at renowned institutions, beginning with his MD degree from the Medical University of Silesia in 1989. He further enhanced his expertise through a fellowship in hematology in 1990. His early career was focused on internal medicine and hematology, which laid the foundation for his future work in hematopoietic stem cell transplantation. In 2008, he achieved habilitation, the Polish equivalent of a postdoctoral qualification, and in 2015, he attained professorship status. Over the years, Professor Markiewicz has continued to enrich his academic portfolio with numerous research accomplishments. He has worked at several leading medical institutions, including the Medical University of Silesia, Katowice, and the Department of Hematology at the University of Masku. His educational journey reflects an unwavering commitment to advancing knowledge in hematology and improving patient care through clinical and laboratory research.
Experience:
Professor Mirosลaw Markiewicz boasts an extensive career in hematology and bone marrow transplantation. From 1992 to 2001, he served as an Assistant Professor at the Medical University of Silesia, where he began his work in the Department of Hematology and Bone Marrow Transplantation. He subsequently became the Head of the Department of Hematology at the same institution, a role he held from 2001 to 2017. During this period, he contributed to expanding the scope of hematological care and research in Poland. Between 2017 and 2019, Professor Markiewicz held a prominent position as Head of the Department at the Department of Hematology at Rzeszรณw University. In 2019, he joined the University of Ransomw, continuing his research and clinical leadership in hematology. His vast clinical experience spans diagnosis, treatment, and transplantation, particularly focusing on myelodysplastic syndrome and acute leukemia, among other complex hematological disorders.
Research Focus:
Professor Mirosลaw Markiewiczโs research primarily revolves around hematopoietic stem cell transplantation (HSCT), bone marrow transplantation (BMT), and the management of hematological malignancies. His work focuses on the clinical outcomes of hematopoietic stem cell transplantation in patients with myelodysplastic syndrome (MDS), acute leukemia, and other hematologic disorders. Additionally, his research explores graft-versus-host disease (GVHD), a common complication following allogeneic stem cell transplantation, and strategies for its prevention and management. One of his primary areas of interest is the use of novel conditioning regimens, such as treosulfan-based conditioning, and their comparison with traditional therapies in improving patient outcomes. Furthermore, Professor Markiewicz has contributed to studies on the genetic predisposition to hematological cancers and the molecular mechanisms of disease progression. His publications, covering clinical trials, transplant outcomes, and immunological factors, have had a significant impact on the field of hematology and transplantation.
Publications Top Notes:
- “Alogeneic hematopoietic stem cell transplantation with CD14-selected CITT cells add-back in high-risk patients” ๐งฌ๐
- “Hematopoietic stem cell transplantation with minor biocompatibility antigen disparities” โ๏ธ๐งฌ
- “Treating rapid development of unclassified myeloid lineage acute leukaemia with trisomy 6 and U2AF1 mutation” ๐ฌโก
- “Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS” ๐๐ฌ
- “The role of lifestyle and environmental factors in the pathogenesis of multiple myeloma” ๐ฑ๐งฌ
- “Fludarabine-treosulfan versus fludarabine-melphalan conditioning in older AML patients” ๐งช๐
- “Polymorphisms within autophagy-related genes as susceptibility biomarkers for multiple myeloma” ๐งฌ๐
- “Graft-versus-host disease and survival in patients with MDS after treosulfan- versus busulfan-based conditioning” ๐ฌ๐งฌ
- “Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation” ๐งช๐งฌ
- “Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes” ๐โ๏ธ
Conclusion:
Prof. Mirosลaw Markiewiczโs work represents the cutting edge of hematology research, particularly in stem cell transplantation and the treatment of hematologic malignancies. His academic rigor, innovative research, and clinical expertise make him a deserving candidate for the Research for Best Researcher Award.